AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

Provided By PR Newswire

Last update: Nov 28, 2022

Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI

NEW YORK, Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes ("ASPI"). ASPI priced its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $5.0 million before deducting underwriting discounts, commissions, and other offering expenses.